This article or section has multiple issues. Please help improve the article or discuss these issues on the talk page. It does not cite any references or sources. Please help improve it by citing reliable sources. Tagged since January 2009. It may require general cleanup to meet Wikipedia's quality standards. Tagged since January 2009.

The 10/90 gap refers to the statistical finding of the Global Forum for Health Research that only ten per cent of worldwide expenditure on health research and development is devoted to the problems that primarily affect the poorest 90 per cent of the world's population.

Among other efforts to address this issue are recent proposals for a Global R&D treaty, and the creation of the nonprofit pharmaceutical company OneWorld Health which develops new and affordable medicines for neglected diseases.

The 10/90 gap has been criticized on the grounds that "neglected diseases" actually comprise a relatively small disease burden compared to pneumonia, diarrhea, tobacco and obesity-related diseases, and that many of the diseases most prevalent in poorer countries are either preventable or easily treatable.[1]

[edit] See also

• World Health Organization

[edit] References

[edit] External links

• Global Forum for Health Research
• 10/90 Report on Health Research 2003-2004

This medical treatment article is a stub. You can help Wikipedia by expanding it. v • d • e